Back to Results
First PageMeta Content
Health / Amino acids / Catecholamines / Prodrugs / Medical statistics / Orphan drug / L-DOPA / Clinical trial / Drug discovery / Pharmacology / Pharmaceutical sciences


OTCQB: AMBS Developing clinical-stage products in neurology, psychiatry and orphan indications BUSINESS UPDATE CONFERENCE CALL April 9, 2015
Add to Reading List

Document Date: 2015-05-01 11:35:14

Open Document

File Size: 904,62 KB

Share Result on Facebook

City

Georgetown / /

Company

Solvay / Cutanogen Corporation / FINANCIAL REVIEW / Lonza Walkersville / OUTLOOK / /

Country

United States / /

Event

FDA Phase / M&A / Labor Issues / /

Facility

Lincoln Park Capital Facility / neurology/psychiatry pipeline / Building Solid Fundamentals Executed / /

IndustryTerm

clinical-stage products / /

MedicalCondition

ADHD / Parkinson’s disease / L-Dopa Induced Dyskinesia / retinal artery occlusion / burns / /

Organization

Diagnostics Division / FDA / European Union / Therapeutics Division / /

Person

Retinitis Pigmentosa / /

Position

Private / /

Product

Outlook / BRAIN / Phase / PD-LID Exceptional / /

SocialTag